Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Latest News about XENE

Recent news which mentions XENE

< Previous 1 2 3 Next >
Xenon Pharmaceuticals: Q1 Earnings Insights
Tickers XENE
Tags Market News Benzinga XENE
From Benzinga
Earnings Scheduled For May 9, 2023
Tickers SQSP SSSS SSTI STER
Tags XPEL VRTV TTGT
From Benzinga
Where Xenon Pharmaceuticals Stands With Analysts
Tickers XENE
Tags BZI/AAR Analyst Ratings XENE
From Benzinga
Unlocking Xenon Pharmaceuticals $1B Potential: Analyst Cites Anti-Epileptic Candidate's Untapped Value
Tickers BHC GSK XENE
Tags General News XENE
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2023
Tickers AFL APLM ARGX BSRR
Tags EURN VTRS PDD
From Benzinga
Benzinga Pro's Top 5 Stocks To Watch For Tuesday, April 25, 2023: GM, SNAP, WEN, XENE, CXAI
Tickers CXAI GM SNAP WEN
Tags Market News GM Pre/Market Outlook
From Benzinga
Earnings Scheduled For March 1, 2023
Tickers AAN ACIW ADV AEO
Tags FOLD LSXMA GTHX
From Benzinga
Xenon Pharmaceuticals Earnings Preview
Tickers XENE
Tags Benzinga Market News XENE
From Benzinga
Applied UV (NASDAQ: AUVI) Effectively Doubles Its Size Following A Merger That Could Help Shape The Industry – A Brief Look At The Company
Tickers AUVI XENE XYL
Tags Partner Content Markets Applied UV
From Benzinga
The Latest Analyst Ratings for Xenon Pharmaceuticals
Tickers XENE
Tags Analyst Ratings XENE Market News
From Benzinga
Will 2023 be the year that pharma M&A makes a comeback?
Tickers ALBO AMGN AMYT APLS
Tags AMGN APLS CINC
From MarketWatch
Analyst Ratings for Xenon Pharmaceuticals
Tickers XENE
Tags Market News Benzinga XENE
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 14, 2022
Tickers ABCM ACRS ADM AGRO
Tags LEA HR MRNA
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
Tickers ACHC ACN ACRV ADI
Tags SO JCI STM
From Benzinga
Xenon Pharmaceuticals Earnings Perspective: Return On Capital Employed
Tickers XENE
Tags Benzinga Market News XENE
From Benzinga
Where Xenon Pharmaceuticals Stands With Analysts
Tickers XENE
Tags Analyst Ratings XENE Market News
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 28, 2022
Tickers AGO AMBC AMG APP
Tags NET PENN STNE
From Benzinga
Earnings Scheduled For November 8, 2022
Tickers STVN SUNW TA TAC
Tags SUNW VLDR TAC
From Benzinga
Earnings Preview: Xenon Pharmaceuticals
Tickers XENE
Tags Earnings BZI/EP XENE
From Benzinga
Hurry! 7 Pitiful Nasdaq Stocks to Sell Before 2022 Ends.
Tickers AZN DUOL FIZZ JNJ
Tags JNJ Market News FIZZ
From InvestorPlace
Analyst Sees This Epilepsy Player As 'M&A Sweet Spot'
Tickers XENE
Tags XENE Biotech Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2022
Tickers AAP AB ACI AKUS
Tags Downgrades SCU SCHW
From Benzinga
4 Analysts Have This to Say About Xenon Pharmaceuticals
Tickers XENE
Tags Market News Benzinga Analyst Ratings
From Benzinga
Xenon Pharmaceuticals May Have A Blockbuster Drug In Store, BofA Says
Tickers XENE
Tags Jason Gerberry Market News Analyst Ratings
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 29, 2022
Tickers AERI APLE AVLR AZN
Tags DOW MOLN LSI
From Benzinga
Analyst Ratings for Xenon Pharmaceuticals
Tickers XENE
Tags XENE Analyst Ratings Benzinga
From Benzinga
4 Analysts Have This to Say About Xenon Pharmaceuticals
Tickers XENE
Tags BZI/AAR Market News Benzinga
From Benzinga
What 4 Analyst Ratings Have To Say About Xenon Pharmaceuticals
Tickers XENE
Tags BZI/AAR Analyst Ratings XENE
From Benzinga
Xenon Pharmaceuticals: Q2 Earnings Insights
Tickers XENE
Tags BZI/Recaps Earnings Market News
From Benzinga
Earnings Scheduled For August 9, 2022
Tickers PLNT PLUG PRCH PRGO
Tags SOPH WYNN SUNW
From Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.